Summit Securities Group’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-137
Closed -$4K 488
2024
Q3
$4K Buy
+137
New +$4K ﹤0.01% 316